Quantcast

Latest FDA Stories

2014-07-10 08:27:14

First and only FDA approved naloxone product specifically indicated for emergency therapy in settings where opioids may be present. RICHMOND, Va., July 10, 2014 /PRNewswire/ -- Kaleo, a privately-held pharmaceutical company headquartered in Richmond, Virginia, today announced the United States (U.S.) commercial availability of EVZIO for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression. EVZIO is not a...

2014-07-09 23:14:19

Now cleared by both the FDA and Health Canada, ExcelHealth's iReliev TENS Device Seeks to Provide a Drug Free Pain Relief Alternative. The Company's CEO, Mike Williams Knows First Hand the Effects Pain can Have on an Entire Family. Billings, MT (PRWEB) July 09, 2014 Emerging medical device company, ExcelHealth Inc. has received a license for commercial sale of its first product, the iReliev Pain Management System (ET-1313) from Health Canada. The device, which utilizes...

2014-07-09 23:09:55

On July 7, the FDA announced the recall (Class I) of Langston V2 Dual Lumen Catheters (Models 5540 and 5550), by Vascular Solutions, because the inner catheter may separate during use and cause serious injury. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) July 09, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from...

2014-07-09 23:08:49

Innovation Breakdown, a new book by Joseph V. Gulfo, details a broken system and how even the smallest changes can speed up the time to market for medical innovations that save lives. New York, NY (PRWEB) July 09, 2014 Joseph V. Gulfo​, MD MBA​ has successfully brought three medical innovations through the FDA over the course of his 25 year career. But the third time became a decade-long struggle of Herculean proportions, that included an​ unlawful ​withholding of approval by the...

2014-07-09 23:05:52

A top national clinic for men’s sexual health, NuMale Medical Center today announced that its fifth facility is now open in Omaha, Nebraska. Led by Chief Medical Officer Dr. Christopher Asandra, NuMale offers a vast array of the most state-of-the art, FDA-approved, customized treatments for erectile dysfunction, low testosterone and other issues associated with men’s health. Omaha, NE (PRWEB) July 09, 2014 NuMale Medical Center, a leading provider of sexual dysfunction treatments,...

2014-07-09 23:02:41

The Firm is evaluating hysterectomy cancer lawsuits on behalf of women who experienced the spread of uterine sarcoma and other cancers, allegedly due to the use of power morcellators in laparoscopic hysterectomies and fibroid removals. New York, New York (PRWEB) July 09, 2014 As the Firm continues to evaluate morcellator lawsuits (http://www.gynecaremorcellatorlawsuit.com/) on behalf of women who allegedly experienced the spread of uterine cancers due to the use of power morcellators in...

2014-07-09 12:31:16

LONDON, July 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Antifungal Drugs : Technologies and Global Marketshttps://www.reportbuyer.com/product/2212016/Antifungal-Drugs--Technologies-and-Global-Markets.htmlThis report aims to determine the current status of the global human antifungal market and assess its growth potential over the five-year period from 2013 through 2018. It covers approved human therapeutics along with focusing on therapeutics in...

2014-07-08 23:14:36

On July 2, the FDA announced that Medtronic Duet External Drainage and Monitoring System is recalled (Class I). In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) July 08, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Medtronic Duet External Drainage and Monitoring System. The FDA informed on July 2,...

2014-07-08 23:05:03

Have you experienced intestinal problems after taking Benicar, Azor or Tribenzor? There are current lawsuits being filed on behalf of victims. Toledo, OH (PRWEB) July 08, 2014 The U.S. Food and Drug Administration (FDA) issued a warning on July 3, 2013, that the blood pressure drug, olmesartan medoxomil (marketed as Benicar, Benicar HCT, Azor, Tribenzor, and generics) can cause serious intestinal problems known as sprue-like enteropathy. The FDA also required changes to the labels of...

2014-07-08 23:03:02

PharmacyChecker.com published almost 2000 consumer comments showing that Americans are concerned about new federal regulations expanding the authority of the FDA to destroy safe drug imports for personal use. PharmacyChecker.com submitted public comments to the FDA, offering suggestions that would protect access by Americans to safe and affordable prescription drugs. White Plains, NY (PRWEB) July 08, 2014 PharmacyChecker.com announced the publication on its website of almost 2000 comments...


Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related